Is QA1.791 a billable code?
Yes. QA1.791 is a billable ICD-10-CM code and can be used on claims and superbills for dates of service from October 1, 2026 to September 30, 2027.
ICD-10-CM FY2027 diagnosis code
QA1.791: Familial cancer syndrome with pathogenic BRCA2 mutation
Billable codeValid for dates of service October 1, 2026 to September 30, 2027
QA1.791 is a billable ICD-10-CM diagnosis code for familial cancer syndrome with pathogenic brca2 mutation. It is specific enough to use on an insurance claim, a superbill or a Good Faith Estimate.
Superbill GeneratorStart a superbill with QA1.791 already added.Good Faith EstimateStart a cost estimate with QA1.791 already added.CMS-1500 Claim FormFill a claim form with QA1.791 in box 21.
Other codes in QA1.79 Other inherited neoplasm predisposition syndrome of multiple systems
QA1.791 questions
What does QA1.791 mean?
QA1.791 is the ICD-10-CM code for Familial cancer syndrome with pathogenic BRCA2 mutation.
Code titles come from the official ICD-10-CM files published by the CDC National Center for Health Statistics. Always check payer rules and the clinical record before billing.